NKGen Biotech Announces Collaboration with the Parkinson’s Foundation to Bring Its Novel Natural Killer Cell Therapy to the Clinic for Advanced Parkinson’s Disease SANTA ANA, Calif., Nov. 04, 2022 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc., a biotechnology company harnessing the power of the body’s immune system through the development of natural killer (NK) cell...

Parkinson's Foundation Appoints Utah Tech CEO Cory Pinegar as President and Board Member of Newly Formed Rocky Mountain Chapter Board of Advisors SALT LAKE CITY, June 08, 2022 (GLOBE NEWSWIRE) -- The Parkinson's Foundation has named visionary entrepreneur Cory Pinegar as President of the Rocky Mountain Chapter Board of Advisors and Board...

Adamas Pharmaceuticals Launches “Dyskinesia Is A Jerk™,” a Campaign to Raise Awareness and Highlight the Impact of Parkinson’s Disease Dyskinesia - Despite significant impact on daily life and the ability to treat primary symptoms of Parkinson’s disease dyskinesia (uncontrolled jerking or twisting movements), symptoms are often not recognized...